US HB6465 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on November 21 2023 - 25% progression
Action: 2023-11-24 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 21 2023 - 25% progression
Action: 2023-11-24 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
Title
PLASMA Act Preserving Life-saving Access to Specialty Medicines in America Act
Sponsors
| Rep. Richard Hudson [R-NC] | Rep. Greg Murphy [R-NC] | Rep. Donald Davis [D-NC] | Rep. Wiley Nickel [D-NC] |
| Rep. Scott Peters [D-CA] | Rep. Larry Bucshon [R-IN] | Rep. Brian Fitzpatrick [R-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-11-24 | House | Referred to the Subcommittee on Health. |
| 2023-11-21 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2023-11-21 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/6465/all-info |
| Text | https://www.congress.gov/118/bills/hr6465/BILLS-118hr6465ih.pdf |
